Convertible Redeemable Preferred Stock and Stockholders' Equity - Additional information (Details) - shares |
6 Months Ended | 12 Months Ended | |
---|---|---|---|
Apr. 01, 2025 |
Jun. 30, 2025 |
Dec. 31, 2024 |
|
Convertible Redeemable Preferred Stock and Stockholders' Equity | |||
Issuance of common stock in connection with warrant exercise (in shares) | 2,989,887 | 6,235,998 | |
Aggregate shares issued upon exercise of warrants (in shares) | 1 | 1 | |
February 2025 Placement Agency Agreement | |||
Convertible Redeemable Preferred Stock and Stockholders' Equity | |||
Aggregate shares issued upon exercise of warrants (in shares) | 475,713 | ||
December 2024 Inducement Warrants | |||
Convertible Redeemable Preferred Stock and Stockholders' Equity | |||
Issuance of common stock in connection with warrant exercise (in shares) | 2,513,703 | ||
February 2024 Public Offering | Common stock purchase warrants | |||
Convertible Redeemable Preferred Stock and Stockholders' Equity | |||
Aggregate shares issued upon exercise of warrants (in shares) | 12,068 | 328,483 |
X | ||||||||||
- Definition Number of common shares issued as a result of the exercise of warrants. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|